Shantell Laketa Heiber

Array ( [id] => 1587494 [patent_doc_number] => 06482414 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Cold-adapted equine influenza viruses' [patent_app_type] => B1 [patent_app_number] => 09/506286 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73898 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482414.pdf [firstpage_image] =>[orig_patent_app_number] => 09506286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301102 [patent_doc_number] => 06251678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Human papillomavirus vaccine formulations' [patent_app_type] => 1 [patent_app_number] => 9/496812 [patent_app_country] => US [patent_app_date] => 2000-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3754 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251678.pdf [firstpage_image] =>[orig_patent_app_number] => 496812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307429 [patent_doc_number] => 06241990 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Immunogenic composition containing inactivated swine infertility and respiratory Syndrome virus' [patent_app_type] => 1 [patent_app_number] => 9/494869 [patent_app_country] => US [patent_app_date] => 2000-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 12743 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/241/06241990.pdf [firstpage_image] =>[orig_patent_app_number] => 494869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4270205 [patent_doc_number] => 06280740 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Formulations of recombinant papillomavirus vaccines' [patent_app_type] => 1 [patent_app_number] => 9/331290 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4376 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280740.pdf [firstpage_image] =>[orig_patent_app_number] => 331290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380633 [patent_doc_number] => 06548068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule' [patent_app_type] => B1 [patent_app_number] => 09/480340 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 16764 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548068.pdf [firstpage_image] =>[orig_patent_app_number] => 09480340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435771 [patent_doc_number] => 06355414 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Immunopotentiating formulations for vaccinal use' [patent_app_type] => B1 [patent_app_number] => 09/380790 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 6319 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355414.pdf [firstpage_image] =>[orig_patent_app_number] => 09380790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043600 [patent_doc_number] => 06867033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Treatment of papillomavirus infections' [patent_app_type] => utility [patent_app_number] => 09/868009 [patent_app_country] => US [patent_app_date] => 1999-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 6806 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867033.pdf [firstpage_image] =>[orig_patent_app_number] => 09868009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 948741 [patent_doc_number] => 06962777 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-08 [patent_title] => 'IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPS), HOMOGENEOUS VLP AND CAPSOMERE COMPOSITIONS PRODUCED BY SAID METHODS; USE THEREOF AS VEHICLE FOR IMPROVED PURIFICATION, AND DELIVERY OF ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 09/457594 [patent_app_country] => US [patent_app_date] => 1999-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 18515 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962777.pdf [firstpage_image] =>[orig_patent_app_number] => 09457594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404225 [patent_doc_number] => 06264958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Genes of kaposi\'s sarcoma associated herpesvirus' [patent_app_type] => 1 [patent_app_number] => 9/230637 [patent_app_country] => US [patent_app_date] => 1999-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 31 [patent_no_of_words] => 26068 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/264/06264958.pdf [firstpage_image] =>[orig_patent_app_number] => 230637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280516 [patent_doc_number] => 06642032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Uses of avian interferon gamma (IFN-)' [patent_app_type] => B2 [patent_app_number] => 09/443218 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21809 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642032.pdf [firstpage_image] =>[orig_patent_app_number] => 09443218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439354 [patent_doc_number] => 06495138 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays' [patent_app_type] => B1 [patent_app_number] => 09/434476 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10297 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495138.pdf [firstpage_image] =>[orig_patent_app_number] => 09434476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640401 [patent_doc_number] => 06395512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'DNA coding for a peptide of a papilloma virus main capside protein and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/430010 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 3329 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395512.pdf [firstpage_image] =>[orig_patent_app_number] => 09430010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376061 [patent_doc_number] => 06261573 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Immunoadjuvants' [patent_app_type] => 1 [patent_app_number] => 9/426361 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3225 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261573.pdf [firstpage_image] =>[orig_patent_app_number] => 426361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296834 [patent_doc_number] => 06251406 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Attenuated microorganism strains and their uses' [patent_app_type] => 1 [patent_app_number] => 9/413807 [patent_app_country] => US [patent_app_date] => 1999-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 8572 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251406.pdf [firstpage_image] =>[orig_patent_app_number] => 413807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085647 [patent_doc_number] => 06133015 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV-, and which produces large amounts of uncontaminated HHV-8 virus' [patent_app_type] => 1 [patent_app_number] => 9/410815 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5706 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133015.pdf [firstpage_image] =>[orig_patent_app_number] => 410815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4264682 [patent_doc_number] => 06306581 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Diagnostic assay method and kit for the detection of HHV-8 infection' [patent_app_type] => 1 [patent_app_number] => 9/409616 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5723 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306581.pdf [firstpage_image] =>[orig_patent_app_number] => 409616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413328 [patent_doc_number] => 06509020 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Replication-competent herpes simplex virus' [patent_app_type] => B1 [patent_app_number] => 09/381733 [patent_app_country] => US [patent_app_date] => 1999-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12309 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509020.pdf [firstpage_image] =>[orig_patent_app_number] => 09381733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560280 [patent_doc_number] => 06361778 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Carboxyl terminal of papillomavirus L1 region is not required for formation of virus-like particles' [patent_app_type] => B1 [patent_app_number] => 09/397680 [patent_app_country] => US [patent_app_date] => 1999-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4315 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361778.pdf [firstpage_image] =>[orig_patent_app_number] => 09397680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4390780 [patent_doc_number] => 06296853 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'E6 binding proteins' [patent_app_type] => 1 [patent_app_number] => 9/384301 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 37561 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/296/06296853.pdf [firstpage_image] =>[orig_patent_app_number] => 384301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489784 [patent_doc_number] => 06416945 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPS)' [patent_app_type] => B1 [patent_app_number] => 09/379615 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 18190 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416945.pdf [firstpage_image] =>[orig_patent_app_number] => 09379615 [rel_patent_id] =>[rel_patent_doc_number] =>)